Over the past 12 months, 9 insiders at CYTOKINETICS INC filed 83 open-market SEC Form 4 transactions on CYTK: 0 purchases worth $0 and 83 sales worth $41.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 26 | Robert I BlumPresident & CEO, Director | SELL | 7.5K | $80.87 | $607K |
| Jul 21, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $80.59 | $282K |
| Jul 7, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $86.62 | $303K |
| Jul 1, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $84.92 | $637K |
| Jul 1, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $85.80 | $1.3M |
| Jul 1, 26 | Sung LeeEVP, Chief Financial Officer | SELL | 1.1K | $87.79 | $98K |
| Jun 29, 26 | Sung LeeEVP, Chief Financial Officer | SELL | 3.1K | $85.00 | $266K |
| Jun 24, 26 | Sung LeeEVP, Chief Financial Officer | SELL | 38.7K | $82.30 | $3.2M |
| Jun 23, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $79.51 | $278K |
| Jun 15, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $70.46 | $528K |
| Jun 9, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $67.98 | $238K |
| Jun 1, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $74.08 | $1.1M |
| Jun 1, 26 | Kaye Edward M. Md | SELL | 2.9K | $76.09 | $223K |
| Jun 1, 26 | B Lynne Parshall | SELL | 5.0K | $74.08 | $370K |
| May 27, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $77.21 | $579K |
| May 19, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $75.69 | $265K |
| May 14, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $77.92 | $584K |
| May 5, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 11.3K | $77.25 | $875K |
| May 5, 26 | John T Henderson | SELL | 20.0K | $75.97 | $1.5M |
| May 5, 26 | Sung LeeEVP, Chief Financial Officer | SELL | 23.9K | $76.87 | $1.8M |
| May 5, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $77.37 | $271K |
| May 5, 26 | Wendell Wierenga | SELL | 4.0K | $75.00 | $302K |
| May 1, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.9K | $65.00 | $1.0M |
| Apr 30, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $63.26 | $949K |
| Apr 29, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $59.62 | $447K |
| Apr 21, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $65.69 | $230K |
| Apr 15, 26 | Robert I BlumPresident & CEO | SELL | 7.5K | $65.38 | $490K |
| Apr 15, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 7.4K | $66.02 | $492K |
| Apr 7, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 3.5K | $65.21 | $228K |
| Mar 31, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 3.6K | $65.00 | $237K |
| Mar 18, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 1.9K | $62.07 | $120K |
| Mar 17, 26 | Robert I BlumPresident & CEO | SELL | 23.9K | $62.15 | $1.5M |
| Mar 17, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 5.6K | $62.15 | $350K |
| Mar 17, 26 | Sung LeeEVP, Chief Financial Officer | SELL | 4.9K | $62.15 | $307K |
| Mar 17, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 7.6K | $62.15 | $475K |
| Mar 16, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 1.7K | $61.03 | $104K |
| Mar 9, 26 | Robert I BlumPresident & CEO | SELL | 7.9K | $60.72 | $482K |
| Mar 9, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 2.6K | $60.72 | $157K |
| Mar 9, 26 | Fady Ibraham MalikEVP Research & Development | SELL | 2.9K | $60.72 | $177K |
| Mar 5, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $61.88 | $928K |
| Mar 2, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 886 | $61.62 | $55K |
| Mar 2, 26 | B Lynne ParshallDirector | SELL | 5.0K | $61.21 | $306K |
| Feb 5, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $61.93 | $929K |
| Feb 2, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 886 | $62.10 | $55K |
| Jan 5, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 15.0K | $60.28 | $904K |
| Jan 2, 26 | Andrew CallosEVP, Chief Commercial Officer | SELL | 913 | $63.16 | $57K |
| Dec 29, 25 | Andrew CallosEVP, Chief Commercial Officer | SELL | 1.8K | $62.44 | $113K |
| Dec 22, 25 | Wendell WierengaDirector | SELL | 20.0K | $66.14 | $1.3M |
| Dec 16, 25 | Fady Ibraham MalikEVP Research & Development | SELL | 2.2K | $61.24 | $135K |
| Dec 8, 25 | Andrew CallosEVP, Chief Commercial Officer | SELL | 1.0K | $65.96 | $69K |
Over the past 12 months, insiders at CYTOKINETICS INC filed 0 open-market purchases worth $0 and 83 sales worth $41.3M on CYTK, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 27, 26.
9 different insiders at CYTOKINETICS INC filed open-market SEC Form 4 transactions on CYTK over the last 12 months.
InsiderTape plots every CYTK insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CYTOKINETICS INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →